DrugPatentWatch Database Preview
Organon Usa Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?
ORGANON USA INC has thirty approved drugs.
There are five US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.
There are one hundred and seven patent family members on ORGANON USA INC drugs in thirty-four countries and thirty supplementary protection certificates in nine countries.
Summary for Organon Usa Inc
| International Patents: | 107 |
| US Patents: | 5 |
| Tradenames: | 32 |
| Ingredients: | 26 |
| NDAs: | 30 |
Drugs and US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-001 | Mar 23, 2004 | RX | Yes | Yes | 7,563,763 | Start Trial | Start Trial | ||||
| Organon Usa Inc | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 000552-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-004 | Feb 11, 2005 | RX | Yes | Yes | 7,563,763 | Start Trial | Start Trial | ||||
| Organon Usa Inc | REMERON | mirtazapine | TABLET;ORAL | 020415-002 | Jun 14, 1996 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-001 | Jan 12, 2001 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Organon Usa Inc | LIQUAEMIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 000552-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-002 | Mar 23, 2004 | 5,767,251 | Start Trial |
| Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-003 | Jan 12, 2001 | 5,178,878 | Start Trial |
| Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-002 | Mar 23, 2004 | 7,563,763 | Start Trial |
| Organon Usa Inc | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | 4,957,119 | Start Trial |
| Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | 4,237,126 | Start Trial |
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-001 | Mar 17, 1994 | 4,894,369*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ORGANON USA INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for Organon Usa Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3417905 | Start Trial |
| Ukraine | 86404 | Start Trial |
| Brazil | PI0606826 | Start Trial |
| Norway | 20073749 | Start Trial |
| Argentina | 048106 | Start Trial |
| Canada | 2559250 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Organon Usa Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1453521 | 122015000093 | Germany | Start Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
| 1453521 | 93156 | Luxembourg | Start Trial | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
| 1453521 | 15C0050 | France | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
| 0136011 | 2000C/027 | Belgium | Start Trial | PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124 |
| 1380301 | CA 2009 00017 | Denmark | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
| 1214076 | C01214076/01 | Switzerland | Start Trial | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
